As of 2024, there are over 500 million people with diabetes globally, and diabetes significantly impacts human health and biochemical levels. To address this challenge, Continuous Glucose Monitoring (CGM) remains the mainstream solution in the market.
Dexcom and Abbott have launched over-the-counter CGM products "G6" and "FreeStyle Libre Series," respectively, to capture the general diabetes consumer market. Subsequently, Medtronic's CGM product, Guardian Connect, also entered the market.
In 2023, Abbott generated $5.3 billion in global sales with its FreeStyle Libre series, while Dexcom's revenue exceeded $3.6 billion.
Since 2021, Chinese brands such as Sibionics, Yuwell Medical, and Sinocare have entered this field, providing global diabetes patients with more choices and cost-effective solutions.
The Mean Absolute Relative Difference (MARD) value is the most commonly used metric for evaluating the accuracy of CGM products. It represents the average absolute error between all CGM values and matched reference values. A smaller MARD percentage indicates that the CGM values are closer to the reference glucose values, while a larger percentage indicates greater disparity.
Abbott FreeStyle Libre 2 has a MARD value of 9.3%, and Dexcom G6 has a MARD value of 9.0%. Chinese Yuwell CT3 has a MARD value of 9.3%, and Yuwell CT15 has a MARD value of 9.07%, achieving internationally advanced standards. These products have received CE and MDR certifications.
For patients who require long-term use, Yuwell offers a more cost-effective solution compared to Abbott, Dexcom, and Sibionics, alleviating the financial burden of health investments. Interested click：Blood Glucose Monitoring System Sensor CT3.
Performance Advantages:
Calibration-free
1-hour initialization
Display values in real-time
9.07% MARD accuracy
14 days to wear
IP58 waterproof and dustproof
real-time data sharing
Sensor validity period: 12 months
3 minutes to calculate a blood glucose value
High and low blood glucose alarm/severe low blood glucose alarm (less than 3.1)
Measurement range 1.7-27.8mmol/L
No finger pricks
No scanning
Comfortable to wear for 14 days
Customizable Alerts and Alarm
7 glucose trend arrows
4 options for glucose timeline
Statistics and Daily Reports can be outputted
Share real-time data with up to 20 people
Allow logging of meals, exercise, and insulin
Real-time High and Low alerts to take action
Can help reduce HbA1C
Can help reduce Hypoglycemic Events
The CGM Continuous Blood Glucose Monitoring System Sensor CT3 represents a significant advancement in diabetes management.